GPI and colorectal cancer: A novel promising target for anti-cancer agents is the receptor for autocrine motility factor/phosphoglucose isomerase (AMF/PGI), known as gp78/AMFR, that was recently identified as one of 189 genes mutated at significant frequency in breast and colorectal cancer [6].